Posted On: 09/18/2014 11:56:35 AM
Post# of 89564
$HALO News
Amazon gains on June event; PVH sinks on results 3:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 9:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 8:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 4:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 6:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 9:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 8:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 12:40 p.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 6:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 2:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 4:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 1:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 11:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 8:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 11:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 10:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo with Modified FOLFIRINOX for Advanced Pancreatic Cancer 8:04 a.m. Today - benzinga.com
InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO 11:01 a.m. Sept. 17, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – AUXL SLXP ENDP HALO 8:45 a.m. Sept. 17, 2014 - InvestorPlace.com
Recent Price Decline Creates An Attractive Entry Point For Halozyme 10:35 a.m. Sept. 16, 2014 - Seeking Alpha
Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog 1:50 p.m. Sept. 15, 2014 - Zacks.com
Halozyme Is Worth Betting On 12:02 p.m. Sept. 15, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:06 a.m. Sept. 15, 2014 - benzinga.com
FDA gives thumbs up to Hyqvia 1:26 p.m. Sept. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI ANAC HALO IRWD 2:00 p.m. Sept. 10, 2014 - InvestorPlace.com
Why You Shouldn't Bet Against Halozyme Therapeutics (HALO) Stock - Tale of the Tape 8:42 a.m. Sept. 8, 2014 - Zacks.com
Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog 5:00 p.m. Sept. 5, 2014 - Zacks.com
Hottest Healthcare Stocks Now – EXAS ACHN HALO CLDX 9:00 a.m. Sept. 3, 2014 - InvestorPlace.com
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:35 a.m. Sept. 3, 2014 - benzinga.com
Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog 10:53 a.m. Aug. 14, 2014 - Zacks.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2014 Results - Earnings Call Transcript 6:50 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:32 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – IRWD IPXL SGEN PCRX 7:30 a.m. Aug. 6, 2014 - InvestorPlace.com
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 9:00 a.m. Today - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 8:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 7:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 8:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 4:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 1:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 9:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 8:00 a.m. June 25, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The JMP Securities 2014 Healthcare Conference 4:30 p.m. June 17, 2014 - PR Newswire - PRF
Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions 3:00 p.m. June 15, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF
Halozyme To Resume PEGPH20 Clinical Program In Pancreatic Cancer 4:05 p.m. June 4, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Jefferies 2014 Global Health Care Conference 4:30 p.m. May 29, 2014 - PR Newswire - PRF
Baxter Provides U.S. Regulatory Update on HyQvia,Its Investigational Subcutaneous Treatment for Primary Immunodeficiency 9:02 a.m. May 21, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The UBS 2014 Global Health Care Conference 6:00 p.m. May 14, 2014 - PR Newswire - PRF
Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences 12:22 p.m. May 14, 2014 - PR Newswire - PRF
Amazon gains on June event; PVH sinks on results 3:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 9:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 8:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 4:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 6:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 9:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 8:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 12:40 p.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 6:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 2:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 4:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 1:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 11:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 8:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 11:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 10:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo with Modified FOLFIRINOX for Advanced Pancreatic Cancer 8:04 a.m. Today - benzinga.com
InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO 11:01 a.m. Sept. 17, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – AUXL SLXP ENDP HALO 8:45 a.m. Sept. 17, 2014 - InvestorPlace.com
Recent Price Decline Creates An Attractive Entry Point For Halozyme 10:35 a.m. Sept. 16, 2014 - Seeking Alpha
Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog 1:50 p.m. Sept. 15, 2014 - Zacks.com
Halozyme Is Worth Betting On 12:02 p.m. Sept. 15, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:06 a.m. Sept. 15, 2014 - benzinga.com
FDA gives thumbs up to Hyqvia 1:26 p.m. Sept. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI ANAC HALO IRWD 2:00 p.m. Sept. 10, 2014 - InvestorPlace.com
Why You Shouldn't Bet Against Halozyme Therapeutics (HALO) Stock - Tale of the Tape 8:42 a.m. Sept. 8, 2014 - Zacks.com
Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog 5:00 p.m. Sept. 5, 2014 - Zacks.com
Hottest Healthcare Stocks Now – EXAS ACHN HALO CLDX 9:00 a.m. Sept. 3, 2014 - InvestorPlace.com
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:35 a.m. Sept. 3, 2014 - benzinga.com
Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog 10:53 a.m. Aug. 14, 2014 - Zacks.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2014 Results - Earnings Call Transcript 6:50 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:32 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – IRWD IPXL SGEN PCRX 7:30 a.m. Aug. 6, 2014 - InvestorPlace.com
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 9:00 a.m. Today - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 8:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 7:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 8:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 4:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 1:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 9:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 8:00 a.m. June 25, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The JMP Securities 2014 Healthcare Conference 4:30 p.m. June 17, 2014 - PR Newswire - PRF
Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions 3:00 p.m. June 15, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF
Halozyme To Resume PEGPH20 Clinical Program In Pancreatic Cancer 4:05 p.m. June 4, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Jefferies 2014 Global Health Care Conference 4:30 p.m. May 29, 2014 - PR Newswire - PRF
Baxter Provides U.S. Regulatory Update on HyQvia,Its Investigational Subcutaneous Treatment for Primary Immunodeficiency 9:02 a.m. May 21, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The UBS 2014 Global Health Care Conference 6:00 p.m. May 14, 2014 - PR Newswire - PRF
Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences 12:22 p.m. May 14, 2014 - PR Newswire - PRF
(0)
(0)
